OBJECTIVES: Galectin-3 is a member of the glycoprotein family, actively involved in various biological interactions including cell growth, cell adhesion, cell differentiation and apoptosis. The aim of this study was to analyze the expression of galectin-3 in clear cell renal carcinoma and to assess its prognostic significance. METHODS: The expression of galectin-3 was analyzed by immunohistochemistry in 149 clear cell renal carcinomas. The levels were correlated to established clinical parameters such as nuclear grade, pathological stage, lymph node, distant metastasis, and patients' survival. RESULTS: In normal kidney tissue, the expression of galectin-3 was found to be uniformly present in the tubular epithelial cells. A decrease of antigen expression levels were significantly associated with higher T-stages (P < 0.02), unfavourable long-term prognosis in univariate Kaplan-Meier (P < 0.007) and multivariate Cox proportional hazard analyses (P < 0.04). Univariate analysis could demonstrate an association with tumor-specific death with decreased galectin-3 expression, whereas multivariate analysis failed to prove the aforementioned observation. CONCLUSION: Our results suggest that a loss of galectin-3 expression is involved in renal carcinogenesis.
OBJECTIVES:Galectin-3 is a member of the glycoprotein family, actively involved in various biological interactions including cell growth, cell adhesion, cell differentiation and apoptosis. The aim of this study was to analyze the expression of galectin-3 in clear cell renal carcinoma and to assess its prognostic significance. METHODS: The expression of galectin-3 was analyzed by immunohistochemistry in 149 clear cell renal carcinomas. The levels were correlated to established clinical parameters such as nuclear grade, pathological stage, lymph node, distant metastasis, and patients' survival. RESULTS: In normal kidney tissue, the expression of galectin-3 was found to be uniformly present in the tubular epithelial cells. A decrease of antigen expression levels were significantly associated with higher T-stages (P < 0.02), unfavourable long-term prognosis in univariate Kaplan-Meier (P < 0.007) and multivariate Cox proportional hazard analyses (P < 0.04). Univariate analysis could demonstrate an association with tumor-specific death with decreased galectin-3 expression, whereas multivariate analysis failed to prove the aforementioned observation. CONCLUSION: Our results suggest that a loss of galectin-3 expression is involved in renal carcinogenesis.
Authors: Gabriel A Rabinovich; Linda G Baum; Nicola Tinari; Roberto Paganelli; Clara Natoli; Fu Tong Liu; Stefano Iacobelli Journal: Trends Immunol Date: 2002-06 Impact factor: 16.687
Authors: G Choufani; N Nagy; S Saussez; H Marchant; P Bisschop; M Burchert; A Danguy; S Louryan; I Salmon; H J Gabius; R Kiss; S Hassid Journal: Cancer Date: 1999-12-01 Impact factor: 6.860
Authors: H P Hahn; M Pang; J He; J D Hernandez; R-Y Yang; L Y Li; X Wang; F-T Liu; L G Baum Journal: Cell Death Differ Date: 2004-12 Impact factor: 15.828
Authors: Judith S Knapp; Soum D Lokeshwar; Ulrich Vogel; Jörg Hennenlotter; Christian Schwentner; Mario W Kramer; Arnulf Stenzl; Axel S Merseburger Journal: World J Urol Date: 2012-08-15 Impact factor: 4.226
Authors: Mario W Kramer; Sandra Waalkes; Jörg Hennenlotter; Jürgen Serth; Arnulf Stenzl; Markus A Kuczyk; Axel S Merseburger Journal: Oncol Lett Date: 2010-07-01 Impact factor: 2.967
Authors: Tamara Straube; Alexandra F Elli; Christoph Greb; Axel Hegele; Hans-Peter Elsässer; Delphine Delacour; Ralf Jacob Journal: J Exp Clin Cancer Res Date: 2011-09-29
Authors: Christoph-A von Klot; Mario W Kramer; Inga Peters; Joerg Hennenlotter; Mahmoud Abbas; Ralph Scherer; Thomas Rw Herrmann; Arnulf Stenzl; Markus A Kuczyk; Juergen Serth; Axel S Merseburger Journal: BMC Clin Pathol Date: 2014-04-03